The Pennant Group, Inc. (NASDAQ:PNTG – Get Rating) has earned an average recommendation of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $16.20.
A number of research analysts recently weighed in on PNTG shares. TheStreet raised The Pennant Group from a “d+” rating to a “c” rating in a research note on Tuesday, March 7th. Stifel Nicolaus raised The Pennant Group from a “hold” rating to a “buy” rating and raised their target price for the company from $15.00 to $16.00 in a report on Monday, February 27th. Truist Financial raised their target price on The Pennant Group from $12.00 to $15.00 and gave the company a “hold” rating in a report on Monday, February 27th. VNET Group reaffirmed a “maintains” rating on shares of The Pennant Group in a report on Tuesday, May 9th. Finally, Royal Bank of Canada lowered their target price on The Pennant Group from $18.00 to $14.00 in a report on Tuesday, May 9th.
Insider Buying and Selling at The Pennant Group
In other The Pennant Group news, Director Barry M. Smith acquired 25,536 shares of the business’s stock in a transaction on Monday, March 6th. The stock was purchased at an average price of $15.00 per share, for a total transaction of $383,040.00. Following the transaction, the director now owns 43,699 shares in the company, valued at approximately $655,485. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Barry M. Smith bought 25,536 shares of the company’s stock in a transaction dated Monday, March 6th. The stock was bought at an average price of $15.00 per share, for a total transaction of $383,040.00. Following the completion of the transaction, the director now directly owns 43,699 shares in the company, valued at approximately $655,485. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Barry M. Smith bought 4,464 shares of the company’s stock in a transaction dated Friday, March 3rd. The shares were purchased at an average price of $14.95 per share, with a total value of $66,736.80. Following the transaction, the director now owns 18,163 shares of the company’s stock, valued at $271,536.85. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 31,232 shares of company stock worth $463,378. 10.30% of the stock is currently owned by insiders.
Institutional Investors Weigh In On The Pennant Group
The Pennant Group Trading Up 1.0 %
Shares of PNTG stock opened at $12.37 on Monday. The stock has a 50-day simple moving average of $12.96 and a 200 day simple moving average of $12.10. The Pennant Group has a fifty-two week low of $8.68 and a fifty-two week high of $19.48. The stock has a market capitalization of $367.88 million, a P/E ratio of 49.48, a P/E/G ratio of 1.65 and a beta of 2.08. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.44.
The Pennant Group (NASDAQ:PNTG – Get Rating) last released its quarterly earnings results on Thursday, February 23rd. The company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.03. The business had revenue of $124.67 million during the quarter, compared to analyst estimates of $117.60 million. The Pennant Group had a return on equity of 13.16% and a net margin of 1.54%. On average, sell-side analysts expect that The Pennant Group will post 0.57 earnings per share for the current fiscal year.
The Pennant Group Company Profile
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
- Get a free copy of the StockNews.com research report on The Pennant Group (PNTG)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.